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ABSTRACT
Objectives: This prospective study aimed to assess the effectiveness of foramen ovale examination in classifying prenatal 
hypoplastic left heart syndrome (HLHS) in accordance with the new classification groupings for congenital heart defects.
Material and methods: The analysis included 145 fetuses with HLHS, diagnosed and monitored between 2008 and 
2015 in Prenatal Cardiology Department at Polish Mother’s Memorial Hospital Research Institute in Lodz. The main criteria 
for classifying our study population into three sub-groups was was the presence of a foramen ovale restriction, which we 
diagnosed by evaluating the diameter and blood flow through the foramen ovale. Of the total group, 73.8% (n = 107) were 
classified as severe planned, 24.1% (n = 35) as severe urgent, and 2.1% (n = 3) as the severest group.
Results: Comparing the severe planned and the severe urgent HLHS groups showed: gestational age of delivery 38 vs 
38 weeks respectively (p = 0.45); cesarean delivery 62% vs 79.2% (p = 0.15); neonatal birth weight 3110 g vs 2985 g (p = 0.2); 
Apgar score 9 vs 9 points; survival rate 65.8% vs 61.9% (p = 0.8); and hospitalization 38 vs 46.5 days (p = 0.059). Prenatal 
qualification for the group of severe urgent HLHS was characterized by 100% sensitivity, 80.6% specificity and a low posi-
tive predictive value of 9.5%.
Conclusions: 
1. Prenatal qualification into the group of severe urgent CHD based on the features of foramen ovale was characterized 
by high sensitivity, a satisfying specificity and a low positive predictive value.
2. Prenatally diagnosed foramen ovale restriction may be a predictor of longer hospitalization, but not of a need for 
an urgent Rashkind procedure. 
3. New classifications of CHDs allowed clinicians to determine prognoses and to plan optimal multi-specialized care which 
resulted in similar outcomes between the severe planned and severe urgent HLHS groups. 
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INTRODUCTION
Hypoplastic left heart syndrome (HLHS) is one of the 
most common congenital heart defect (CHD) diagnosed 
prenatally. According to data from the Polish Nationwide 
Registry of Fetal Cardiac Pathology (www.orpkp.pl) from 
the years 2004 to 2018, HLHS accounted for 9.1% of the 
8317 CHDs diagnosed prenatally [1]. Due to the abnormal 
four-chamber cardiac view that is routinely seen when con-
ducting the screening exam, the prenatal detection rate for 
HLHS is high [1, 2]. Patient management for HLHS in the 
fetus depends on the fetal hemodynamic status in the 3rd 
trimester of pregnancy. New classifications for CHDs primar-
ily categorize HLHS according to the anticipated postnatal 
status of the newborn and on the assessed urgency for 
treatment [3–5]. As such, individual HLHS cases are assigned 
to one of the following three groups:
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 Ū severe planned HLHS: HLHS does not require urgent 
postnatal treatment — the newborn is born in good 
condition and requires only prostaglandin E1 iv infu-
sion, and can be prepared for the first stage of planned 
cardiac surgery
 Ū severe urgent HLHS: HLHS requires, in addition to pros-
taglandin E1 iv infusion, urgent (first 24 hours) treatment 
in a catheterization laboratory (cath lab)
 Ū severest HLHS: HLHS during the first minutes of postna-
tal life is cyanotic, does not respond to iv prostaglandin 
E1 infusion, and is deteriorating within minutes or within 
the next few hours. 
Prenatal echocardiographic monitoring in the 3rd tri-
mester allows qualification of the fetus or newborn into one 
of three groups. As a result, it is possible to set an optimal 
plan and synchronize the actions of obstetricians, neona-
tologists, pediatric cardiologists, interventional cardiologists 
and cardiac surgeons [6–8].
Objectives 
This prospective study aimed to assess the effectiveness 
of foramen ovale examination in classifying prenatal HLHS 
in accordance with the new CHD classifications.
MATERIAL AND METHODS
The analysis included 145 fetuses with HLHS diagnosed 
and monitored in Prenatal Cardiology Department at Polish 
Mother’s Memorial Hospital Research Institute in Lodz be-
tween 2008 and 2015. Of the total group, 73.8% (107/145) 
were classified as severe planned, 24.1% (35/145) as severe 
urgent, and 2.1% (3/145) as the severest group (Fig. 1).
The criteria for assigning our study subjects to a particu-
lar group included evaluation of the foramen ovale (FO) re-
striction by echocardiographic fetal heart examination using 
parameters such as the FO diameter, maximum blood flow 
velocity through the FO and assessment of the blood flow 
spectra in the pulmonary veins. The severe planned cases of 
HLHS were determined when the FO diameter was greater 
than 3mm, the maximum blood flow velocity through the 
FO was less than 100 cm/s, and the pulmonary venous 
blood flow spectra was normal. The severe urgent cases 
were diagnosed when the FO diameter was ≤ 3 mm, the 
maximum flow velocity through the FO was greater than or 
equal to 100 cm/s, and the blood flow spectra through the 
lung veins was assessed as abnormal. The features of the 
severest form of HLHS were complete closure of the FO, 
and no interatrial blood flow accompanied by an extremely 
abnormal pulmonary venous blood flow spectra. The results 
of the last fetal echocardiographic study before delivery 
were considered decisive.
In 25 of 145 diagnosed fetus cases, there was no data 
on the continuation of the pregnancy, nor any neonatal fol-
low-up data. Of the 120 gravidas for whom the follow-up data 
was available, 2 had decided to terminate their pregnancies 
(1.6%). Both cases were classified as severe planned defects.
The study groups were compared using the following 
parameters: gestational age of delivery, percentage of cae-
sarean deliveries, newborn’s birth weight, Apgar score in the 
first minute of life, the percentage of cases requiring urgent 
treatment (defined as the need to perform the Rashkind 
procedure in the first day of postnatal life), survivability until 
discharge from the hospital, and days of hospitalization.
For nominal variables, percent values were calculated. 
For continuous variables with normal data distribution, 
mean values and standard deviations were calculated; and 
for continuous variables with non-normal data distribution 
median values were calculated. Nominal variables were 
compared using the Fisher test, and continuous variables 
were compared using the t-Student test in cases of normal 
data distribution, or, using the U Mann-Whitney test in cases 
of non-normal data distribution (Tab. 1). 
RESULTS
In the severe planned HLHS group (n = 91) the me-
dian gestational age of delivery was 38 weeks (IQR 37–
40 weeks), which was similar to that of the severe urgent 
HLHS group (n = 23), where the calculated median was 
38 weeks (IQR 37–39 weeks) (U Mann-Whitney test p = 0.45). 
In the severest HLHS group (n = 2), one newborn was born at 
36 weeks of gestation and the other at 39 weeks of gestation.
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Figure 1. Prenatal classification of HLHS cases to respective risk groups
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In the severe planned HLHS group, the percentage of ce-
sarean deliveries was 62% (57/92), while in the severe urgent 
HLHS group it was 79.2% (19/24) (Fisher test p = 0.15). In the 
severest HLHS group, both patients had vaginal delivery. 
In the severe planned HLHS group (n = 91) the mean birth 
weight was 3110g (SD ± 486 g) and the median birth weight 
was 3150 g (IQR 2800–3400 g), while in the severe urgent 
HLHS group (n = 24) the mean was 3050 g (SD ± 425 g) and 
the median was 2985 g (IQR 2770–3228 g) (U Mann-Whitney 
test p = 0.2). In the severest HLHS group (n = 2), the birth 
weights were 2820 g and 3100 g (Tab. 1). In the severe 
planned HLHS group (n = 89) for whom we had Apgar data, 
the median Apgar score in the first minute of postnatal life 
was 9 points (IQR 8–9 points), which was similarly to the 
result for the severe urgent HLHS group (n = 24), where the 
value was 9 points (IQR 9–9 points) (U Mann-Whitney test 
p = 0.24) (Tab. 1). Of the 2 cases in the severest HLHS group, 
one newborn scored 7 points, and the second 8 points 
on the Apgar scale. In 16 of 118 newborns, data regard-
ing cardiological and cardiosurgical treatment was incom-
plete and therefore these cases were excluded from further 
analysis. The group of newborns with known cardiological 
and cardiosurgical follow-up history in the local database 
consisted of 102 patients. In this group 77.5% (79/102) of 
cases were prenatally qualified as severe planned HLHS, 
20.6% (21/102) as severe urgent HLHS and 1.9% (2/102) as 
the severest HLHS.
In the group of newborns classified prenatally as severe 
planned HLHS (n = 79), none required cardiac catheteriza-
tion in the first day of life. Thus, it showed that the prenatal 
qualification of those fetuses was 100% (79/79) consistent 
with the short-term postnatal clinical outcome.
In the group of newborns classified prenatally as severe 
urgent HLHS, only 9.5% (2/21) had cardiac catheterization 
(the Rashkind procedure) in the first day of postnatal life. 
Nineteen out of 21 (90.5%) of these cases were confirmed 
to be severe planned HLHS based on postnatal paediatric 
cardiology examinations. 
In the two cases of newborns classified prenatally as 
the severest HLHS, the qualification was correct, as both 
neonates died in the first day of postnatal life.
The efficiency of prenatal assessment of the foramen ovale 
in distinguishing between severe planned and severe urgent 
HLHS cases was evaluated. In our study group, there were: 
 Ū 2 fetuses with prenatally diagnosed severe urgent HLHS, 
which needed the Rashkind procedure in the first day 
of life (true positive cases)
 Ū 19 fetuses with prenatally diagnosed severe urgent 
HLHS, which did not need the Rashkind procedure in 
the first day of life (false positive cases)
 Ū 79 fetuses with prenatally diagnosed severe planned 
HLHS, which did not need the Rashkind procedure in 
the first day of life (true negative cases)
 Ū No fetuses with prenatally diagnosed severe planned 
HLHS, which needed the Rashkind procedure in the first 
day of life (false negative cases).
The sensitivity of this method, defined as the number 
of true positive cases divided by the sum of the number 
of true positive cases and false negative cases was 100%.
The specificity of this method, defined as the number 
of true negative cases divided by the sum of the number 
of true negative cases and false positive cases was 80.6%.
The positive predictive value of this method, defined 
as the number of true positive cases divided by the sum of 
Table 1. Comparison of the data from prenatally diagnosed severe planned and severe urgent HLHS cases
Severe planned HLHS Severe urgent HLHS
Gestational age of delivery 
(median)
38 weeks 
(IQR 37–40 weeks);
(n = 91)
38 weeks 
(IQR 37–39 weeks); 
(n = 23)
P = 0.45 
(U Mann-Whitney test)
Cesarean delivery 62% (57/92) 79.2% (19/24) P = 0.15 (Fisher test)
Birth weight (mean and 
median)
mean: 3110 g 
(SD ± 486 g); 
median: 3150 g 
(IQR 2800–3400 g); 
(n = 91)
mean: 3050 g 
(SD ± 425 g);
median: 2985 g 
(IQR 2770–3228 g); (n = 24)
P = 0.2 
(U Mann-Whitney test)
Apgar score (median) 9 points (IQR 8-9 points); (n = 89)
9 points 
(IQR 9-9 points);
(n = 24)
P = 024 
(U Mann-Whitney test)
Survival until hospital 
discharge 65.8% (52/79) 61,9% (13/21)
P = 0.8 
(Fisher test)
Duration of hospitalization 
(median)
38 days
(IQR 31–46.5 days); (n = 49)
46.5 days 
(IQR 35.25–69.75 days);
(n = 12)
P = 0.059 
(U Mann-Whitney test)
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the number of true positive cases and false positive cases 
was 9.5%.
In the group of newborns classified prenatally as severe 
planned HLHS the survival rate until hospital discharge was 
65.8% (52/79), while in the severe urgent HLHS group the 
survival rate was 61.9% (13/21) (Fisher’s test p = 0.8) (Fig. 2). 
In the group of patients with prenatally diagnosed se-
vere planned HLHS who survived until hospital discharge 
(n = 49), the median duration of hospitalization was 38 days 
(IQR 31–46.5 days), while in the severe urgent HLHS group 
(n = 12) the median was 46.5 days (IQR 35.25–69.75 days) 
(U Mann-Whitney test p = 0.059).
DISCUSSION
Implementation of the new classifications of fetuses 
with congenital heart defects in several centers of prenatal 
cardiology around the world shows the need to introduce 
changes not only in the classification method, but also the 
consulting and management practices with fetal CHDs. Pru-
etz from Los Angeles divided patients with CHD into four 
classification groups with regard to the varying needs 
for emergency neonatal cardiac intervention (ENCI) [9]. 
According to his classifications, all cases of HLHS belong 
to the ENCI 3 group, which is characterized by the need 
for intravenous infusion of prostaglandin E1 and the pos-
sible need of urgent cardiac intervention [3, 4, 9]. The CHD 
classifications created by Respondek-Liberska and Slodki 
take into account the fact that fetuses and newborns with 
HLHS are not a homogeneous group of patients, and that 
instead, their hemodynamic state differs during the 3rd 
trimester of pregnancy, depending on the patency and size 
of the prenatally assessed foramen ovale [5, 7, 8]. Donofrio 
et al. from Washington reached the same conclusion and 
divided patients with HLHS into three groups which they 
called “Levels of Care” (LOC) groups [3]. In their classification, 
HLHS newborns with prenatally diagnosed non-restricted 
FO were assigned to LOC 2. According to Donofrio et al., the 
diagnosis of non-restricted FO is made by evaluating the 
ratio of the forward blood flow to the reversal flow Velocity 
Time Integral (VTI f/r) in the pulmonary veins, measured 
using the Spectral Doppler. The ultrasound criterion of 
non-restricted FO is a VTI f/r ratio > 5. Due to the presence 
HLHS cases
n = 102
Severest
n = 2
Severe
urgent
n = 21
Severe
planned
n = 79
Survivors
n = 1
Hospital
death
n = 1
Survivors
n = 12
Hospital
death
n = 7
Survivors
n = 52
Hospital
death
n = 27
Death in
1 day
of life
n = 2
st
Urgent
Rashkind
procedure
n = 2
No urgent
Rashkind
procedure
n = 19
No urgent
Rashkind
procedure
n = 79
Figure 2. Postnatal follow-up of the respective HLHS groups
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of a ductus-dependent CHD, the newborns in this group 
received an intravenous infusion of prostaglandin E1 to 
maintain patency of the ductus arteriosus, and they were 
prepared for the planned first stage of cardiosurgical treat-
ment. In Respondek-Liberska and Slodki, the classification 
LOC 2 corresponded to a severe planned HLHS. Newborns 
with prenatally diagnosed restricted FO were assigned to 
LOC 3. The ultrasound criterion for inclusion in this LOC 
3 group was a VTI f/r ratio in pulmonary veins blood flow 
spectra of < 5 to > 3. In such cases, after delivery, the blood 
flow from the left to the right atrium is obstructed, which 
results in an insufficient volume of oxygenated blood get-
ting into the systemic circulation. Blood pressure in the left 
atrium increases, leading to passive lung congestion and 
hemodynamic instability. In order to prevent this dramatic 
natural history, it is necessary to urgently widen the FO via 
balloon atrial septosomy (the Rashkind procedure) [10]. 
In the Respondek-Liberska and Slodki classification, LOC 
3 corresponded to a severe urgent HLHS. Newborns with 
prenatally diagnosed extreme restriction of the FO or an in-
tact atrial septum were assigned to the LOC 4 group (Fig. 3). 
The ultrasound criterion for inclusion in this group was a VTI 
f/r ratio in pulmonary veins blood flow spectra of < 3. The 
prognosis in such newborns is the most severe and in the 
Washington center the Rashkind procedure was performed 
in the first minute after birth in the delivery room [3, 4, 11]. 
Polish delivery rooms do not allow the performance of 
such necessary operations due to a lack of adequate facili-
ties. If we want to give newborns with the severest HLHS 
a better chance of survival, we must make efforts to create 
multi-specialized delivery rooms combined with a cath-
eterization laboratory [6]. An important issue is the fact that 
the prenatal diagnosis that assigns fetuses to one of the 
three mentioned groups is not final. In many cases HLHS 
is an evolving defect, meaning the restriction of the FO 
can develop and deepen during pregnancy. Accordingly, 
HLHS fetuses require serial echocardiographic monitoring. 
Therefore, in this group of patients fetal echocardiography 
is indicated to be performed at least every 4 weeks, and 
after the 36th week of gestation, with a frequency of up 
to every 7 days. Such a procedure allows us to predict the 
postnatal status of the newborn in the most accurate way [8]. 
In the newborns with a highly restrictive FO or intact atrial 
septum, the prognosis is worse than in the newborns with 
unobstructed inter-atrial communication, even if the Rash-
kind procedure is performed immediately after delivery. 
In American centers, the survival rate of the HLHS group 
with a highly restrictive FO or intact atrial septum, after the 
Rashkind procedure and the first stage of cardiac surgery 
was 33%–48% [12–14]. by comparison, the survival rate in 
the HLHS group without a restrictive FO was 74% [15]. Fur-
thermore, the FO restriction increases the blood pressure 
in the left atrium, which damages the pulmonary veins and 
leads to their arterialisation; and this process is already tak-
ing place during fetal life [13]. For this reason, attempts are 
being made to dilate a restrictive FO in utero, using either 
balloon atrial septostomy or stent implantation in the FO. 
However, according to data from the International Fetal 
Cardiac Intervention Registry database, prenatal treatment 
of FO restriction does not increase the survival rate up to 
the time of hospital discharge and is associated with a 13% 
risk of intrauterine fetal demise [16, 17]. More optimistic 
conclusions are drawn from the research conducted at the 
Boston center, where the six-month survival rate of patients 
treated in utero was significantly greater than for those in 
whom FO balloon septostomy was only performed after 
birth (69% vs. 38%, respectively) [10]. Intrauterine dilation 
of the FO to at least 3 mm was associated with better blood 
saturation and a lower incidence of postnatal balloon atrial 
septostomy [18].
Fetal echocardiographic examination enables us to pre-
dict the prenatal and postnatal hemodynamical state of the 
fetus and the newborn and to determine the necessity of 
urgent help [3, 19, 20]. According to current knowledge, the 
most precise method used to detect FO restriction is asses-
ment of the blood flow in the pulmonary veins using the 
spectral Doppler technique. Restriction of the FO is associat-
ed with an increased blood pressure in the left atrium, which 
results in the occurrence of reversal blood flow in the pulmo-
nary veins. The greater the narrowing of the FO, the greater 
the reversal blood flow. The Velocity Time Integral (VTI) is 
measured for the forward and the reversal pulmonary blood 
flow respectively. A forward to reversal VTI ratio (VTI f/r) 
of less than 5 and greater than 3 is associated with moder-
ate FO restriction (Fig. 4), whereas a VTI f/r of less than 3 is 
present in severe FO restriction and intact atrial septum 
cases [21–23]. The method described above is character-
Figure 3. Prenatally predicted severe urgent HLHS with FO < 3 mm. 
Postnatally confirmed severe planned HLHS
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ized by a sensitivity close to 100%, 94–98% specificity and 
positive predictive value of 75–91% [22, 24]. In the material 
we studied, the HLHS fetuses were classified and assigned 
to respective risk groups depending on the evaluation of 
the the FO diameter (measured using the 2D Ultrasound 
and Color Doppler technique), the maximum velocity of 
blood flow through the FO, and a subjective assessment 
of the blood flow spectra through the pulmonary veins [6]. 
This methodology allowed us to identify fetuses with se-
vere urgent HLHS with a sensitivity of 100% and specificity 
of 80.6%, but it was associated with a very low positive 
predictive value of 9.5% (Tab. 2). M. Taketazu et al. proved 
that the measurement of the FO diameter in the fetus does 
not correlate well with its actual diameter in the newborn 
(Fig. 5, 6). Furthermore, it does not allow us to predict the 
need for an urgent Rashkind procedure [23]. Therefore, it 
seems reasonable to use the VTI f/r ratio in the pulmonary 
veins as the main criterion for assigning HLHS fetuses to 
the group that may require the Rashkind procedure in the 
first day of life (Fig. 7, 8). Such an approach enables a sig-
nificant increase in specificity without losing sensitivity. It 
should be noted, that the criteria used so far have worked 
very well in diagnosing the severest cases of HLHS with 
intact atrial septum, with a sensitivity and specificity of 
100%. A maternal hyperoxygenation test, which involves 
inhalation of 100% oxygen for 10 minutes by the gravida 
Figure 4. Prenatally predicted severe urgent HLHS with FO Vmax flow 
> 100 cm/s, Postnatally confirmed severe planed HLHS
Table 2. Prenatal qualification of the HLHS fetuses to the group of severe urgent CHD - accuracy of prenatal diagnosis
True positive 
(number)
False positive 
(number)
True negative 
(number)
False 
negative 
(number)
Sensitivity Specificity
Positive 
predictive 
value
Negative 
predictive value
2 19 79 0 100.00% 80.60% 9.50% 100.00%
Figure 5. Prenatally predicted severe urgent HLHS with abnormal pul-
monary vein flow, VTI f/r < 3. Postnatally confirmed severe urgent HLHS
Figure 6. Prenatally predicted severest HLHS with total abnormal 
pulmonary vein flow. Postnatally confirmed severest HLHS
Figure 7. Prenatally predicted severe urgent HLHS with abnormal 
pulmonary vein flow, VTI f/r between 3–5. Postnatally confirmed 
severe planned HLHS
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Figure 10. The same patient from figure 7, pulmonary vein flow after 
mother hyperoxygenation, VTI f/r 5, predicted severe planned HLHS
may be useful in detecting HLHS cases requiring urgent 
treatment. Enzensberger et al. showed that in fetuses with 
HLHS and normal inter-atrial communication the maternal 
hyperoxygenation test results in increased fetal lung per-
fusion, leading to a decrease of the pulsatility index of the 
blood flow spectra in the pulmonary veins. In the fetuses 
with restrictive FO, the response of the pulmonary veins 
to maternal hyperoxygenation was significantly less pro-
nounced [25]. The usefulness of hyperoxygenation is still 
the subject of research. In addition to its diagnostic use, it 
is postulated that it may have a long-term beneficial thera-
peutic effect on the hemodynamics of fetuses with CHD 
[26, 27]. Observations show, that in cases of longitudinal 
maternal hyperoxygenation, an improvement in the VTI f/r 
ratio and a change of the HLHS classification from severe 
urgent to severe planned (from LOC3 to LOC2 according to 
Donofrio) can be obtained (Fig. 9, 10). So far, these are the 
only clinical observations and they need to be confirmed by 
statistical analysis with a larger group of patients.
Low positive predictive value is connected mainly to 
inclusion criteria based on FO features which appear too 
sensitive. To improve prediction of severe urgent HLHS the 
primary focus should be on the pulmonary vein flow, fol-
lowed by the FO features. 
Classification, based on FO restriction, to the severe 
urgent and severe planned groups was not a good predictor 
for urgent cardiac intervention (2 urgent interventions in 
a group of 21 severe urgent patients, with a positive predic-
tive value of 9.5%). However, this classification influenced 
the duration of the hospitalization, which tended to be 
longer in the severe urgent group compared with the severe 
planned group (46.5 days vs 38 days, p = 0.059). Similar ob-
servations have not been described in the literature so far.
CONCLUSIONS
1. Prenatal qualification, based on the features of the fora-
men ovale, to the group of severe urgent CHD was char-
acterized by high sensitivity and satisfying specificity, 
but also by a low positive predictive value.
2. Prenatally diagnosed foramen ovale restriction may be 
a factor leading to longer hospitalization but is not an in-
dicator of the need for an urgent Rashkind procedure. 
3. New classifications of CHDs allowed us to determine 
the prognosis and to plan the optimal multi-specialized 
care, which resulted in similar outcomes for the severe 
planned and severe urgent HLHS patients. 
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